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Abstract: To clarify the main humoral triggering factor (histamine and/or
leukotriene) of the early stage of asthma attacks, the release of histamine and
leukotriene C 4 (LTC4) from bronchoalveolar lavage (SAL) cells stimulated with Ca
ionophore A23187 was examined in 7 patients with atopic asthma, and the results
were compared to those in 7 nonatopic asthma patients. 1. The proportion of SAL
basophilic cells was significantly higher in atopic patients than in nonatopic patients
(p<O.05). 2. The content of histamine in SAL fluid was significantly higher in atopic
(2.3mcg/mQ) comparted to that in nonatopic patients (0 mcg/mQ)(p<O.OOn. The
content of LTC4 was high in nonatopic (2.4ng/mQ) than in atopic patients (O.5ng/
mQ), however, this was not significant. 3. The release of histamine from SAL cells
was 32.6% in atopic and 0 % in nonatopic patients, and this was significant
(p<O.001). The release of LTC4 from SAL cells was significantly higher in nonatopic
(11.3ng/10 6 cell) than in atopic (3.5ng/10 6cell)(p<O.02).
The results demonstrate that histamine play more important role in atopic patients
as a main triggering factor of attacks than LTC4. In contrast, in nonatopic patients,
LTC4 is more predominant than histamine during early stage of asthma attacks.
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Introduction
In the onset mechanism of asthma,
humoral factors such as histamine and
leukotrienes in the early stage of asthma
attacks I - 0, and cellular components such as
lymphocytes, neutrophils, eosinophils, and
basophils in the late stage have been shown
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to play important roles 5 -13). Particularly,
release of histamine and leukotrienes in the
early stage are important as the early trig-
gering factor of attacks, since pathophy-
siological changes in the airways of asthma,
such as bronchoconstriction, mucus hyper-
secretion and edema of mucous membrane,
are at first introduced by the release of these
chemical mediators from tissue mast cells I').
Asthma is classified into two types, atopic
and nonatopic, based on the presence or
absence of an IgE-mediated allergic reac-
tion I5). Atopic asthma is often observed in
young patients, having specific IgE antibodies
to allergens. In contrast, nonatopic asthma is
often seen in late onset adult patients, and
shows low serum IgE levels and negative IgE
antibodies to allergens. This suggests that
the main triggering factor of asthma attacks
are different between atopic and nonatopic
asthma patients.
In the present study, to clarify the main
triggering factor of attacks, release of hista-
mine and leukotrienes from inflammatory
cells in the airways was examined in atopic
asthma patients, and the results were com-
pared to those in nonatopic asthma patients.
Subjects and Methods
Seven patients with atopic asthma were
selected in this study to examine the main
humoral triggering factor (histamine and/or
leukotrienes) of IgE-mediated allergic reac-
tion of atopic asthma. They were all sensi-
tive to house dust mite, showing a positive
RAST score (2 + or more) to the allergen.
Seven nonatopic asthma patients were se-
lected as control subjects. Their serum IgE
levels were under 200 IV/ mR and RAST score
to various allergens was negative.
Bronchoalveolar lavage (BAL) was per-
formed according to a previously reported
method l 2-1') when the subjects were attack-
free. Informed consent for this BAL proce-
dure was obtained from all study subjects.
The aspirate obtained by BAL were filtered
through a sterile steel mesh, and the filtrates
were centrifuged at 300 9 for 10 min at 4 C.
The cell pellet was resuspended in Tris ACM.
After the number of cells was adjusted to
10' cells/ mR in Tris ACM, Ca ionophore
A23187 ( 1 meg) was added to the cell suspen-
sion. The mixed solution was then incubated
for 15 min at 37"C and centrifuged at 300 9
for 10 min at 4°C. The histamine content of
both the cells and supernatant fluid were
analyzed by perchloric acid precipitation and
assayed with automated spectrofluorometric
histamine analysis system (Technicon Instru-
ments Co). Histamine release was expressed
as a percentage of total histamine. The
HPLC analysis for extraction and quanti-
fication of LTC4 was performed by a method
described by Lam et aI 16). The extraction of
leukotrienes was performed by a method
using a C18 Sep-Pak (Walters Associates).
The concentration of LTC4 was analyzed by
an HPLC system, Model 510 (Walters Associ-
ate), equipped with an ultraviolet detector.
The column used was a 5 mm X 10em Radial-
Pak cartridge (Shimazu). The results were
expressed as ng/10 6 cells. BAL cytology was
performed by observing 500 cells, excluding
epithelial cells, on smear preparations which
were made from BAL cell suspensions and
stained with May-Giemsa. Regarding mast
cells and basophils in BAL fluid, 1000 cells
were observed and the number of basophilic
cells was calculated. The results were ex-
pressed as percentages of the total number of
cells. In this study, the mean recovery rate at
BAL was 28.8 ± 11.8% (± SD). The total
16 Histamine and LTC4 III atopic asthma
number of cells aspirated into BAL fluid was
8.21 ± 10.2 X 10 6 •
The level of serum IgE was measured by
the radioimmunosorbent test (RIST), and IgE
antibodies against allergens were assessed by
the radioallergosorbent test (RAST).
Statistically significant difference of the
mean was evaluated using the unpaired
Student't test. A value of p<0.05 was re-
garded as significant.
Table 2. Cellular composition of BAL fluid
in patients with asthma studied
Asthma No of BAL cells (%)
type patients Mac Lym Neut Eos Bas
Atopic 7 83.5 11.6 2.4 2.3 0.15
a
±11.2 ± 8.3 ±2.1 ±.1.9 ±O.13
Nonatopic 7 77.4 18,9 2.9 0.9 0.03 3
± 7.9 ±. 7.9 ±2.6 ±1.0 ±.0.05
Mac; macrophages, Lym; lymphocytes, Neut; neutrophils,
Eos; eosinophils, Bas; basophilic cells. a<0.05.
Results
Asthma No of Mean age RAST 2+< serum IgE
type patients (years) to HD (IU/ml)
Table 1. Characteristics of patients with
bronchial asthma studied
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The content of histamine in BAL fluid was
significantly higher in atopic patients (mean
± SD : 2.3 ± 1.5mcg/me) than in nonatopic
patients (mean 0 mcg/m£)(p<O.OOl)(Fig. 1 ).
In contrast, the content of leukotrienes C 4
(LTC4) was higher in nonatopic patients (2.4
± 2.6ng/m£) compared to that in atopic
patients (0.5 ± 1.3ng/me). However, this
was not significant (Fig. 2).
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Table shows characteristics of atopic
and nonatopic asthma patients. Serum IgE
level was remarkably higher in atopic asthma
than in nonatopic asthma. However, this
difference was not significant. Cellular com-
position of BAL fluid in both atopic and
nonatopic subjects was shown in Table 2.
The proportions of BAL lymphocytes,
neutrophils, and eosinophils were not signifi-
cantly different between atopic and nonatopic
asthma patients. The proportion of BAL
basophilic cells was significantly higher in
atopic patients than in nonatopic patients
(p<O.05).
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Fig. 1. Histamine content in BAL fluid III
patients with asthma. a ; p<O.OOl.
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Fig. 3. Release of histamine from BAL cells
in patients with asthma. a ; p<O.OO1.
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Fig. 2. LTC4 content in BAL fluid in pa-
tients with asthma.
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The release of histamine from BAL cells
was 32.6 ± 7.8% in atopic patients and 0
% in nonatopic patients. The histamine re-
lease from BAL cells was significantly higher
in atopic than in nonatopic patients (p<
O.OOl)(Fig. 3). The release of LTC4 from
BAL cells was significantly higher III
nonatopic (11.3 ± 5.8ng/10 6 cells) than
atopic patients (3.5 ± 3.0ng/10 6 cells)(p<O.
02)(Flg.4 ).
Atopic Nonatopic
Asthma type
Fig. 4. LTC4 release from BAL cells in
patients with asthma. a ; p<O.02.
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Discussion
Asthma can be clinically classified into two
types, atopic and nonatopic by the onset
mechanism of attacks. Although there are
some reports suggesting that asthma is al-
most always associated with some type of
IgE-related reactionI7• 18) , there are many
asthma patients who are clinically regarded
as nonatopic, showing negative skin test, low
serum IgE levels, and negative RAST score to
various allergens. Nonatopic asthma clinically
diagnosed is often observed in late onset
(over the age of 40 years) adult patients.
Their attacks often become severe and
intractablel~ 20) within a couple of years from
onset of asthma. The onset mechanism of
attacks, particularly, triggering event III
early stage of attacks in nonatopic asthma is
still unclear. In contrast, in atopic asthma,
IgE-mediated allergic reaction was triggered
by bridging of IgE receptors on mast cell
membrane, followed by release of chemical
mediators such as histamine and leukotri-
enes 1 -'. 21-23).
In recent years, focus has been placed on
inflammatory cell infiltration in the airways
as a main onset mechanism of asthma 5 -14) •
However, release of chemical mediators such
as histamine and leukotrienes has been con-
sidered to be the main mechanism of the
onset of early stage of asthma attacks. The
mechanism is important as triggering factor
of asthma attacks.
In the present study, to clarify whether a
main triggering factor in the early stage of
attacks IS different between atopic and
nonatopic asthma, release of histamine and
leukotrienes from BAL cells was examined in
these two different asthma types. The results
revealed that the release of histamine from
BAL cells was significantly higher in atopic
than in nonatopic asthma. In contrast, the
release of LTC4 from BAL cells was signifi-
cantly higher in nonatopic asthma compared
to that in atopic asthma. These results sug-
gest that histamine is more important as
triggering factor of attacks in atopic asthma
than LTC4, and that LTC4 is more important
than histamine in nonatopic asthma in rela-
tion to early stage of attacks.
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気管支鴨息患者の気管支肺胞細胞からのヒスタミ
ンとロイコトリエンC4遊離-アトピー性犠息に
おけるヒスタミンの役割について一
光延文裕,御船尚志,梶本和宏,横田 聡,
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気管支噂息発作初期に関与する液性因子 (ヒス
タミン,ロイコトリエン)の役割を明らかにする
ために,気管支肺胞洗浄 (BAL)細胞からのカル
シウムイオノフォアA23187によるヒスタミンと
ロイコトリエンC4(LTC4)遊離の検討を行っ
た｡対象はアトピー性鴨息患者 7名,非アトピー
性暗愚患者7名とした｡ 1.BAL液中の好塩基
性細胞の比率は,アトピー性喋息患者において有
andaglng.Bronchoalveolarcelsand the
releaseofhistamineandleukotrienes,LTC4
and LTB4,from leucocytes.Jpn J Clin
lmmun16:44-51,1993.
意に高値を示した｡2.BAL液中ヒスタミン濃
度は非アトピー性瑞息患者 (Omcg/mP)に比し
て,アトピー性喋息患者 (2.3mcg/mP)におい
て有意に高値を示した｡一方,BAL液中LTC4濃
度は,アトピー性瑞息患者 (0.5ng/mP)に比し
て非アトピー性瑞息患者 (2.4ng/mP)において,
高値を示したが,有意差は見られなかった｡3.
BAL細胞からのヒスタミン遊離は非アトピー性
喋息患者 (0%)に比して,アトピー性曝息患者
(32.6%)において有意に高値を示 した｡LTC4
遊離はアトピー性瑞息患者 (3.5ng/106細胞)に
比して,非アトピー性喋息患者 (ll.3ng/106細
胞)において有意に高値を示した｡
以上より,鴨息発作初期に関与する液性因子と
しては,アトピー性鳴息患者においてはヒスタミ
ンが重要であり,非アトピー性喋息患者において
はLTC4が,重要であることが,明らかになった｡
